Literature DB >> 28390264

Selected life-extending interventions reduce arterial CXCL10 and macrophage colony-stimulating factor in aged mouse arteries.

Daniel W Trott1, Lisa A Lesniewski2, Anthony J Donato3.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the industrialized world. Aging is the most predictive risk factor for CVD and is associated with arterial inflammation which contributes to increased CVD risk. Although age-related arterial inflammation has been described in both humans and animals, only a limited number of inflammatory mediators, cytokines and chemokines have been identified. In this investigation we sought to determine whether lifespan extending interventions, including crowded litter early life nutrient deprivation (CL), traditional lifelong caloric restriction (CR) and lifelong Rapamycin treatment (Rap) would attenuate age-related arterial inflammation using multi analyte profiling. Aortas from Young (4-6months), Old (22months), Old CL, Old CR and Old Rap mice were homogenized and cytokine concentrations were assessed using Luminex Multi Analyte Profiling. Chemokines involved in immune cell recruitment, such as CCL2, CXCL9, CXCL10, GMCSF and MCSF, were increased in Old vs. Young (p<0.05). The age-related increase of CXCL10 was prevented by CR (p<0.05 vs. Old). MSCF concentrations were lower in aortas of Rap treated mice (p<0.05 vs. Old). Interleukins (IL), IL-1α, IL-1β and IL-10, were also greater in Old vs. Young mice (p<0.05). These data demonstrate selected lifespan extending interventions can prevent or limit age-related increases in selected aortic chemokines.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Aorta; Caloric restriction; Chemokine; Cytokine; Interleukin; Rapamycin

Mesh:

Substances:

Year:  2017        PMID: 28390264      PMCID: PMC5544385          DOI: 10.1016/j.cyto.2017.03.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  40 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Authors:  Edward G Lakatta
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells.

Authors:  Yang Song; Hua Shen; Dominik Schenten; Peiying Shan; Patty J Lee; Daniel R Goldstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

4.  Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin.

Authors:  Katherine A Blackwell; Joseph P Sorenson; Darcy M Richardson; Leslie A Smith; Osamu Suda; Karl Nath; Zvonimir S Katusic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-19       Impact factor: 4.733

5.  Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans.

Authors:  Anthony J Donato; Alexander D Black; Kristen L Jablonski; Lindsey B Gano; Douglas R Seals
Journal:  Aging Cell       Date:  2008-09-08       Impact factor: 9.304

6.  Beneficial effects of lifelong caloric restriction on endothelial function are greater in conduit arteries compared to cerebral resistance arteries.

Authors:  Ashley E Walker; Grant D Henson; Kelly D Reihl; Elizabeth I Nielson; R Garrett Morgan; Lisa A Lesniewski; Anthony J Donato
Journal:  Age (Dordr)       Date:  2013-09-25

7.  Rapamycin slows aging in mice.

Authors:  John E Wilkinson; Lisa Burmeister; Susan V Brooks; Chi-Chao Chan; Sabrina Friedline; David E Harrison; James F Hejtmancik; Nancy Nadon; Randy Strong; Lauren K Wood; Maria A Woodward; Richard A Miller
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

8.  Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype.

Authors:  Sarah E Gardner; Melanie Humphry; Martin R Bennett; Murray C H Clarke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-02       Impact factor: 8.311

9.  Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction.

Authors:  Richard A Miller; David E Harrison; Clinton M Astle; Elizabeth Fernandez; Kevin Flurkey; Melissa Han; Martin A Javors; Xinna Li; Nancy L Nadon; James F Nelson; Scott Pletcher; Adam B Salmon; Zelton Dave Sharp; Sabrina Van Roekel; Lynn Winkleman; Randy Strong
Journal:  Aging Cell       Date:  2014-02-09       Impact factor: 9.304

10.  Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways.

Authors:  Lisa A Lesniewski; Douglas R Seals; Ashley E Walker; Grant D Henson; Mark W Blimline; Daniel W Trott; Gary C Bosshardt; Thomas J LaRocca; Brooke R Lawson; Melanie C Zigler; Anthony J Donato
Journal:  Aging Cell       Date:  2016-09-22       Impact factor: 9.304

View more
  3 in total

Review 1.  Inflammation as a mediator of arterial ageing.

Authors:  Daniel W Trott; Paul J Fadel
Journal:  Exp Physiol       Date:  2019-08-08       Impact factor: 2.969

2.  T cells mediate cell non-autonomous arterial ageing in mice.

Authors:  Daniel W Trott; Daniel R Machin; Tam T T Phuong; AdeLola O Adeyemo; Samuel I Bloom; R Colton Bramwell; Eric S Sorensen; Lisa A Lesniewski; Anthony J Donato
Journal:  J Physiol       Date:  2021-08       Impact factor: 6.228

Review 3.  Role of Cachexia and Fragility in the Patient Candidate for Cardiac Surgery.

Authors:  Calogera Pisano; Daniele Polisano; Carmela Rita Balistreri; Claudia Altieri; Paolo Nardi; Fabio Bertoldo; Daniele Trombetti; Laura Asta; Maria Sabrina Ferrante; Dario Buioni; Calogero Foti; Giovanni Ruvolo
Journal:  Nutrients       Date:  2021-02-05       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.